Voyager Therapeutics: 3Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Voyager Therapeutics Inc. (VYGR) on Wednesday reported a loss of $15 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 41 cents.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 83 cents per share.
The gene therapy company posted revenue of $20.4 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $3.9 million.
Voyager Therapeutics shares have risen 58% since the beginning of the year. The stock has risen 5.5% in the last 12 months.